SEC 8-K
SEC 8-K: Item 7.01
Official SEC filing update. Items: 7.01.
Item 7.01Accession 0001140361-26-020906
Cigna (CI) Financials, Dividends & Stock Info
Explore comprehensive financial data for Cigna, provided completely free. Analyze revenue, net income, profit margins, dividend history, and key financial ratios to make informed investment decisions.
Data as of (571 days ago)|Source: SEC EDGAR
The information on this page is for informational purposes only and does not constitute investment advice, financial advice, or any recommendation. Billiver does not recommend buying, selling, or holding any security. Past performance is not indicative of future results.
Data may be delayed and accuracy is not guaranteed. All investment decisions are solely your responsibility. Verify information independently and consult a qualified financial advisor before investing. About · Methodology
Cigna (CI) is a health care services company. The company reports annual revenue of $268.1B and net income of $6.5B. Its profit margin is 2.4%.
Cigna Key Financials(TTM Est.)
Revenue (TTM)↑ 11.2%
$268.1B
Net Income (TTM)↑ 73.5%
$6.5B
Profit Margin
2.4%
Top 64% in sector
Return on Equity
15.7%
Top 33% in sector
Data from SEC EDGAR filings. TTM = Trailing Twelve Months.
Cigna Financial Health ScoreFY2025
0/100
Below average; significant concerns in multiple areas
+8 pts YoYProfitability48Liquidity35Growth80Efficiency78
This Financial Health Score is a proprietary metric calculated from SEC EDGAR filings for educational and informational purposes only. It does not constitute investment advice or a recommendation to buy or sell any security. Results vary significantly by industry. Conduct your own research before making investment decisions.
Cigna Official SEC Updates
Official filing updates from SEC EDGAR. Billiver stores internal evidence snapshots for verification, but this page links to the SEC source instead of republishing full filing text.
Open SEC filing
SEC 10-Q
SEC 10-Q
Official SEC filing update.
10-QAccession 0001739940-26-000043
SEC 8-K
SEC 8-K: Item 2.02, 9.01
Official SEC filing update. Items: 2.02, 9.01.
Item 2.02, 9.01Accession 0001140361-26-017971
SEC 8-K
SEC 8-K: Item 5.07
Official SEC filing update. Items: 5.07.
Item 5.07Accession 0001140361-26-017123
SEC DEF 14A
SEC DEF 14A
Official SEC filing update.
DEF 14AAccession 0001739940-26-000023
Source: SEC EDGAR · 5 filings
Informational only. Not investment advice.
Cigna Recent Events
Earnings Results
Shareholder Vote
Leadership Change
Earnings Results
Other Events
Source: SEC EDGAR 8-K Filings
5-Year Revenue & Net Income Trend
Chart shows fiscal year data from SEC EDGAR filings. Hover over data points for details.
As of FY2025 · SEC 10-K · Updated Jul 2, 2026
Revenue Breakdown (FY2024)
See Cigna detailed breakdown →Product
$189.4B76.6%
HomeDeliveryAndSpecialty
$72.5B29.3%
ServiceOther
$584M0.2%
About Cigna
The Cigna Group is an American multinational for-profit managed healthcare and insurance company based in Bloomfield, Connecticut. Cigna's insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups.
- Industry
- Health Care Services
Valuation
Valuation Data UnavailablePrice-based valuation metrics (P/E, P/B) require real-time stock price data which is not included in SEC filings.
Benjamin Graham: Graham recommended P/E ratio not exceed 15 for reasonable valuation. Understanding valuation metrics
Profitability
Thin MarginsROE15.7%
vs 11.6% sector median / 7.7% avg
▼
Generates $15.7 in profit for every $100 of shareholder equity. Higher than 67% in Health Care.
Profit Margin2.4%
vs 4.1% sector median / 2.3% avg
▼
Keeps 2 cents of every dollar in revenue as profit. Higher than 36% in Health Care.
Revenue (TTM)*$268.1B
2nd consecutive year of revenue growth.
Net Income (TTM)*$6.5B
* Some quarterly data is missing. Values are calculated based on annual report figures.
Profit margin of 2.4% is below 5%.
Warren Buffett: Buffett looks for consistent ROE above 20% as a sign of competitive advantage. How to evaluate profitability
Financial Health
Balance Sheet Data LimitedInsufficient data to assess financial health.
Peter Lynch: Lynch: normal balance sheet has 75% equity, 25% debt. Understanding financial health
Dividend
Dividend Data UnavailableDividend yield data is not available from SEC filings. Check the company's investor relations page for dividend information.
As of FY2025 · SEC 10-K · Updated Jul 2, 2026
Cigna 10-Year Revenue, Profit & Cash Flow History
Annual Financials
FY2025 - FY2016| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $274.9B(+11.2%) | $247.1B(+42.0%) | $174.1B(-3.6%) | $180.5B(+17.6%) | $153.6B(+215.7%) | $48.6B(-68.3%) | $153.6B(+215.7%) | $48.6B(+16.4%) | $41.8B(+4.9%) | $39.8B |
| Net Income | $6.0B(+73.5%) | $3.4B(-36.6%) | $5.4B(-20.1%) | $6.8B(+32.5%) | $5.1B(+93.5%) | $2.6B(-48.3%) | $5.1B(+93.5%) | $2.6B(+18.5%) | $2.2B(+21.1%) | $1.8B |
| Total Assets | $157.9B | $155.9B | $152.8B | $143.9B | $154.9B | $155.5B | $155.8B | $153.2B | $61.8B | - |
| Total Debt | - | - | - | - | - | - | - | - | - | - |
| Total Equity | $41.7B | $41.0B | $46.2B | $44.7B | $47.1B | $50.3B | $45.3B | $41.0B | $13.7B | $13.7B |
| Profit Margin | 2.2% | 1.4% | 3.1% | 3.8% | 3.3% | 5.4% | 3.3% | 5.4% | 5.3% | 4.6% |
| ROE | 14.3% | 8.4% | 11.7% | 15.2% | 10.9% | 5.3% | 11.3% | 6.5% | 16.3% | 13.5% |
| ROA | 3.8% | 2.2% | 3.5% | 4.7% | 3.3% | 1.7% | 3.3% | 1.7% | 3.6% | - |
Quarterly Financials
Last 8 quarters| Metric | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $65.5B | $181.5B | $117.8B | $57.3B | $144.2B | $95.1B | $46.5B | $134.8B |
| Net Income | $1.3B | $2.2B | $1.4B | $-212,000,000 | $4.3B | $2.8B | $1.3B | $5.6B |
| Total Assets | $157.9B | $155.9B | $155.9B | $155.9B | $152.8B | $152.8B | $152.8B | $143.9B |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026
Insider Trading
Loading chart...
Loading transactions...
Source: SEC EDGAR Form 4 filings. Only purchase (P) and sale (S) transactions shown.
Cigna Dividend Safety Analysis & Growth History
Dividend Status
Dividend PayerCAGR (5Y)
+157.5%
This company pays dividends. Historical dividend data shown below.
5-year dividend CAGR: +157.5%.
Annual Dividends
2017 - 2025| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Dividend/Share | $0.04 | $0.04 | $0.04 | $0.04 | $4.00 | $4.48 | $4.92 | $5.60 | $4.53 |
| YoY Growth | - | +0.0% | +0.0% | +0.0% | +9900.0% | +12.0% | +9.8% | +13.8% | -19.1% |
| Payments | 1 | 1 | 1 | 1 | 4 | 4 | 4 | 4 | 3 |
| Increased | - | No | No | No | Yes | Yes | Yes | Yes | No |
Learn more: Dividend investing guide | How to evaluate dividend safety
As of FY2025 · SEC 10-K · Updated Jul 2, 2026
Cigna Free Cash Flow & Dividend Coverage
Free Cash Flow
-
FY2025
FCF Margin
-
FCF / Revenue
Operating Cash Flow
$9.6B
Cash from operations
FCF / Net Income
-
Below earnings
Cash Flow History
FY2016 - FY2025| Metric | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | $4.0B | $4.1B | $3.8B | $9.5B | $3.8B | $9.5B | $8.7B | $7.2B | $10.4B | $9.6B |
| CapEx | -$461.0M | -$471.0M | -$528.0M | -$1.1B | - | - | - | - | - | - |
| Free Cash Flow | $3.6B | $3.6B | $3.2B | $8.4B | - | - | - | - | - | - |
| FCF Margin | 8.9% | 8.6% | 6.7% | 5.5% | - | - | - | - | - | - |
Source: SEC EDGAR 10-K filings. FCF = Operating Cash Flow - Capital Expenditures. Free cash flow guide
As of FY2025 · SEC 10-K · Updated Jul 2, 2026
Cigna Risk Factors
Company-disclosed SEC risk factors
Risk factors are disclosed by the company in its SEC Form 10-K, Item 1A. Billiver does not classify or summarize company-specific legal, operational, financial, or market risks here.
Sector context: Health Care. This is not a Billiver risk assessment for CI.
Source note: the SEC Form 10-K includes Item 1A, "Risk Factors." The full risk-factor text should be read from the company’s own SEC filing.
Cigna FAQ
What is Cigna's annual revenue?
Cigna (CI) reported $268.1 billion in trailing twelve-month (TTM) revenue. This financial data is compiled from SEC EDGAR 10-K filings.
Is Cigna profitable?
Yes, Cigna is profitable with a 2.4% net profit margin and $6.5 billion in net income (TTM). All figures from SEC EDGAR 10-K filings.
Does Cigna pay dividends?
Yes, Cigna pays regular dividends. View the full dividend history and payout analysis on this page.
What is Cigna's financial health score?
Cigna has a financial health score of 59/100 (Grade: D), evaluating profitability, solvency, liquidity, and growth based on SEC EDGAR data.
How many years of Cigna financial data are available?
10 years of financial data are available for Cigna from FY2016 to FY2025. All figures are compiled from SEC EDGAR 10-K filings.